Canadian research university specializing in population health, cardiovascular data infrastructure, and digital screening within European health consortia.
McMaster University is a major Canadian research university in Hamilton, Ontario, with deep strengths in population health, cardiovascular research, and data science. In H2020, they contributed epidemiological expertise and health data infrastructure to European consortia — particularly around cardiovascular disease screening, infectious disease data repositories, and ageing population studies. Their Population Health Research Institute (PHRI) is a globally recognized centre for large-scale clinical trials and health outcomes research. They also hosted Marie Skłodowska-Curie fellows across diverse fields from theoretical chemistry to philosophy, reflecting broad research capacity.
Core contributor to MINDMAP (mental wellbeing in ageing populations), euCanSHare (EU-Canada cardiovascular data infrastructure), AFFECT-EU (atrial fibrillation screening), and SMILE (digital health for ageing).
euCanSHare built a cardiovascular data catalogue with FAIR principles; RECODID created integrated repositories for infectious disease cohorts; both focused on data harmonization, governance, and interoperability.
AFFECT-EU developed digital screening tools for atrial fibrillation with biomarker-based risk stratification; SMILE applied smart living environments for ageing support.
Hosted MSCA fellows for High level CDFT (conceptual density functional theory), DRAMATIC (microbial process modelling), and Extending MEDT (molecular electron density theory).
Participated in RealVision, an MSCA training network on HDR imaging, light field images, and perceptual quality assessment.
In the early period (2016–2018), McMaster's H2020 involvement was split between population health studies (MINDMAP) and hosting individual MSCA fellows in fundamental research — chemistry, image processing, and democratic theory. From 2019 onward, a clear shift emerged toward health data infrastructure: data sharing platforms, FAIR-compliant repositories, cardiovascular data catalogues, and digital screening tools. The recent portfolio shows a university that moved from contributing domain expertise in individual health studies to building the data backbone that connects them.
McMaster is moving toward large-scale health data interoperability and digital prevention tools — expect them to seek partners with cloud, AI, or regulatory expertise for future health data projects.
McMaster never coordinated an H2020 project — they consistently joined as a participant or third-party expert, which is typical for a non-EU institution contributing specialized knowledge to European-led consortia. With 101 unique partners across 23 countries, they integrate into large, diverse consortia rather than leading small teams. Their high proportion of third-party roles (8 of 13) reflects their position as a globally sought-after expert that European projects bring in for specific capabilities, particularly in health outcomes research.
McMaster has collaborated with 101 unique partners across 23 countries, giving them a wide European network despite being a Canadian institution. Their connections span major EU health research hubs, particularly through large RIA health projects and the MSCA mobility programme.
McMaster brings a rare non-European perspective to EU health consortia — their PHRI is one of the world's leading centres for large-scale cardiovascular and population health studies, with access to Canadian and global patient cohorts. As a Canadian partner, they enable true EU-Canada research bridges (as in euCanSHare), which is increasingly valued in Horizon programmes that reward international cooperation. Their combination of clinical trial expertise, health data science capability, and willingness to serve as a specialist contributor makes them a low-friction, high-value addition to any health-focused consortium.
